Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of medicine compositions with sarpogrelate to treating or preventing fatty livers, liver fibrosis and/or liver injury

A technology of sargrelate, medicine, applied in the field of medicine

Active Publication Date: 2016-12-07
CHINA PHARM UNIV
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0011] At present, there are no reports on the use of serotonin 2 receptor antagonist sarcogrelate and / or serotonin synthesis inhibitors for the treatment or prevention of fatty liver, liver fibrosis, and liver damage

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of medicine compositions with sarpogrelate to treating or preventing fatty livers, liver fibrosis and/or liver injury
  • Application of medicine compositions with sarpogrelate to treating or preventing fatty livers, liver fibrosis and/or liver injury
  • Application of medicine compositions with sarpogrelate to treating or preventing fatty livers, liver fibrosis and/or liver injury

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0115] 1 part by weight of sagrelate, 5 parts by weight of p-chlorophenylalanine, and commonly used auxiliary materials such as dextrin to prepare granules using conventional techniques.

Embodiment 2

[0117] 1 part by weight of sagogrelate, 2 parts by weight of p-chlorophenylalanine, and microcrystalline cellulose and other commonly used auxiliary materials are compressed into tablets.

Embodiment 3

[0119] 2 parts by weight of sagrelate, 1 part by weight of p-chlorophenylalanine, and commonly used auxiliary materials such as dextrin are made into granules using conventional techniques, and then poured into hard capsule skins to make capsules.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of medicines, and discloses application of medicine compositions with sarpogrelate to treating or preventing fatty livers, liver fibrosis and / or liver injury. As proved from experiments, the application has the advantages that the fatty livers due to high fat and high cholesterol can be obviously reversed by the aid of the medicine compositions, and the liver fibrosis and the liver injury due to combination effects of the high fat, the high cholesterol and streptozotocin irritation can be obviously reversed.

Description

Technical field [0001] The invention belongs to the field of medicine, and relates to the use of a pharmaceutical composition containing sagrelate for the treatment or prevention of fatty liver, liver fibrosis and / or liver injury, and specifically relates to a serotonin 2 receptor antagonist sagrelate and The use of a compound pharmaceutical composition of a combination of a serotonin synthesis inhibitor for treating or preventing fatty liver, liver fibrosis and / or liver injury. Background technique [0002] Fatty liver is directly manifested by obvious lipid deposits in the liver. A significant increase in triglyceride (TG) content in liver tissue can be detected. Obvious lipid droplets in liver cells can be observed in tissue sections. Further liver disease can develop into liver fibrosis and liver damage. Liver fibrosis can be determined by observing the formation of liver fibrous tissue by special staining of tissue sections and detecting the content of hydroxyproline (a uni...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K45/06A61K31/225A61P1/16A61P3/06A61K31/198A61K31/165
CPCA61K31/165A61K31/198A61K31/225A61K45/06A61K2300/00
Inventor 傅继华
Owner CHINA PHARM UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com